AbbVie profit beats on Humira demand; cheers Trump tax plan

(Reuters) - AbbVie Inc reported a bigger-than-expected quarterly profit, lifted by demand for its flagship drug, Humira, and called President Donald Trump's tax plan "encouraging".
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news